3 Big Pharma Stocks Set to Succeed
That disclaimer that the Securities and Exchange Commission requires mutual funds to provide to investors isn't one to overlook: Past performance really may not be indicative of future results. This applies to mutual funds and to individual stocks.
For big pharma stocks, though, you can get a sense for what their prospects could look like. Current products and pipeline candidates can help investors determine which stocks have the best chances at being winners. In my view, three big pharma stocks look set to succeed: AbbVie (NYSE: ABBV), Allergan (NYSE: AGN), and Celgene (NASDAQ: CELG). Here's why.
Image source: Getty Images.
Source: Fool.com
Amgen Inc. Aktie
355,40 €
1,25 %
Starke Kaufneigung bei Amgen Inc., mit mehr Buy- als Sell-Einschätzungen.
Für Amgen Inc. ergibt sich ein Potenzial von -5.46%, obwohl das Kursziel von 336 € den aktuellen Kurs von 355.4 € unterschreitet.
